Baseline circulating soluble factors as predictors of immune-related adverse events (irAEs) in patients (pts) with metastatic clear cell renal carcinoma (mRCC) treated with nivolumab: A translational NIVOREN GETUG-AFU 26 study.

被引：0
|
作者：
Carril-Ajuria, Lucia
Naigeon, Marie
Dalban, Cecile
Desnoyer, Aude
Rioux-Leclercq, Nathalie
Sautes-Fridman, Catherine
Meylan, Maxime
Vano, Yann-Alexandre
Beusenlick, Benoit
Chouaib, Salem
de Oliveira, Caroline
Tantot, Florence
Flippot, Ronan
Escudier, Bernard
Albiges, Laurence
Chaput, Nathalie
机构：
[1] Inst Gustave Roussy, Med Oncol, Villejuif, France
[2] Gustave Roussy, Lab Immunomonitoring Oncol, Villejuif, France
[3] Ctr Leon Berard, Lyon, France
[4] AP HP, Paris, France
[5] Pontchaillou Univ Hosp Ctr, Rennes, France
[6] Sorbonne Univ, Univ Paris Cite, INSERM, Ctr Rech Cordeliers, Paris, France
[7] Univ Paris Cite, Dept Med Oncol, Hop Europeen Georges Pompidou, AP HP Ctr,Inst Canc Paris CARPEM,, Paris, France
[8] Univ Hosp Leuven, Gen Med Oncol, B-3000 Leuven, Belgium
[9] Gustave Roussy Canc Campus, Villejuif, France
[10] Gustave Roussy, Lab Immunooncol, F-94800 Villejuif, France
[11] UNICANCER, Le Kremlin Bicetre, France
[12] Gustave Roussy, Villejuif, MA, France
[13] Univ Paris Sud, Dept Canc Med, Gustave Roussy Canc Campus, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
724
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Baseline circulating soluble factors as predictors of response to nivolumab in metastatic clear cell renal cell carcinoma (mRCC): A validation study within the NIVOREN GETUG-AFU 26 translational study.
    Carril-Ajuria, Lucia
    Naigeon, Marie
    Dalban, Cecile
    Desnoyer, Aude
    Rioux-Leclercq, Nathalie
    Sautes-Fridman, Catherine
    Meylan, Maxime
    Vano, Yann-Alexandre
    Beusenlick, Benoit
    Chouaib, Salem
    De Oliveira, Caroline
    Tantot, Florence
    Flippot, Ronan
    Escudier, Bernard
    Albiges, Laurence
    Chaput, Nathalie
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [2] The impact of baseline peripheral cytokines on survival in metastatic clear cell renal cell carcinoma (RCC) treated with nivolumab: NIVOREN GETUG-AFU 26 Translational study.
    Carril, Lucia
    Naigeon, Marie
    Dalban, Cecile
    Desnoyer, Aude
    Rioux-Leclercq, Nathalie
    Sautes-Fridman, Catherine
    Meylan, Maxime
    Vano, Yann-Alexandre
    Beusenlick, Benoit
    Chouaib, Salem
    de Oliveira, Caroline
    Tantot, Florence
    Escudier, Bernard
    Albiges, Laurence
    Chaput, Nathalie
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [3] Safety and efficacy of nivolumab in metastatic renal cell carcinoma (mRCC): Results from the NIVOREN GETUG-AFU 26 study.
    Albiges, Laurence
    Negrier, Sylvie
    Dalban, Cecile
    Gravis, Gwenaelle
    Chevreau, Christine
    Oudard, Stephane
    Laguerre, Brigitte
    Barthelemy, Philippe
    Borchiellini, Delphine
    Gross-Goupil, Marine
    Geoffrois, Lionnel
    Brihoum, Meryem
    Escudier, Bernard
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [4] NIVOREN GETUG-AFU 26 translational study: Baseline peripheral cytokines predict survival in metastatic clear cell renal carcinoma (RCC) treated with nivolumab
    Ajuria, L. Carril
    Naigeon, M.
    Dalban, C.
    Desnoyer, A.
    Rioux-Leclercq, N.
    Sautes-Fridman, C.
    Meylan, M.
    Vano, Y.
    Beuselinck, B.
    Chouaib, S.
    de Oliveira, C.
    Tantot, F.
    Escudier, B.
    Albiges, L.
    Chaput, N.
    ANNALS OF ONCOLOGY, 2021, 32 : S704 - S705
  • [5] Baseline cytokine levels according to the line of treatment in patients with metastatic clear cell renal cell carcinoma treated with nivolumab: NIVOREN GETUG-AFU 26 translational study
    Rainho, L. T.
    Albiges, L.
    Flippot, R.
    Ajuria, L. Carril
    Dalban, C.
    Escudier, B.
    Naigeon, M.
    Desnoyer, A.
    Teixeira, M.
    Chaput-Gras, N.
    ANNALS OF ONCOLOGY, 2023, 34 : S1027 - S1027
  • [6] Primary tumour response in patients treated with nivolumab for metastatic renal cell carcinoma (mRCC): Results of the GETUG-AFU 26 NIVOREN trial
    Courcier, J.
    Dalban, C.
    Laguerre, B.
    Ladoire, S.
    Barthelemy, P.
    Oudard, S.
    Joly, F.
    Mescam, G. Gravis
    Chevreau, C. M.
    Geoffrois, L.
    Deluche, E.
    Rolland, F.
    Topart, D.
    Culine, S.
    Negrier, S.
    Mahammedi, H.
    Tantot, F.
    Escudier, B.
    Flippot, R.
    Albiges, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S560 - S560
  • [7] Efficacy and safety of nivolumab in patients with metastatic renal cell carcinoma (mRCC) and brain metastases: Preliminary results from the GETUG-AFU 26 (Nivoren) study.
    Escudier, Bernard J.
    Chabaud, Sylvie
    Borchiellini, Delphine
    Gravis, Gwenaelle
    Chevreau, Christine
    Brachet, Pierre Emmanuel
    Geoffrois, Lionnel
    Laguerre, Brigitte
    Mahammedi, Hakim
    Negrier, Sylvie
    Rolland, Frederic
    Goupil, Marine Gross
    Habibian, Muriel
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] Safety and efficacy of nivolumab in elderly patients with metastatic clear cell renal cell carcinoma: Analysis of the NIVOREN GETUG-AFU 26 study
    Mourey, Loic
    Rainho, Larissa Tames
    Dalban, Cecile
    Carril-Ajuria, Lucia
    Negrier, Sylvie
    Chevreau, Christine
    Gravis, Gwenaelle
    Thibault, Constance
    Laguerre, Brigitte
    Barthelemy, Philippe
    Borchiellini, Delphine
    Gross-Goupil, Marine
    Geoffrois, Lionnel
    Rolland, Frederic
    Thiery-Vuillemin, Antoine
    Tantot, Florence
    Chaput, Nathalie
    Naigeon, Marie
    Teixeira, Marcus
    Escudier, Bernard
    Flippot, Ronan
    Albiges, Laurence
    EUROPEAN JOURNAL OF CANCER, 2024, 201
  • [9] Validation of the lung immune prognostic index (LIPI) in patients with metastatic renal cell carcinoma treated with nivolumab in the GETUG-AFU 26 NIVOREN trial
    Lavaud, Pernelle
    Dalban, Cecile
    Negrier, Sylvie
    Chevreau, Christine
    Gravis, Gwenaelle
    Oudard, Stephane
    Laguerre, Brigitte
    Barthelemy, Philippe
    Borchiellini, Delphine
    Goupil, Marine Gross
    Geoffrois, Lionnel
    Rolland, Frederic
    Thiery-Vuillemin, Antoine
    Joly, Florence
    Ladoire, Sylvain
    Tantot, Florence
    Mezquita, Laura
    Escudier, Bernard
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [10] Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study
    Carril-Ajuria, Lucia
    Desnoyer, Aude
    Meylan, Maxime
    Dalban, Cecile
    Naigeon, Marie
    Cassard, Lydie
    Vano, Yann
    Rioux-Leclercq, Nathalie
    Chouaib, Salem
    Beuselinck, Benoit
    Chabaud, Sylvie
    Barros-Monteiro, Janice
    Bougouin, Antoine
    Lacroix, Guillaume
    Colina-Moreno, Irelka
    Tantot, Florence
    Boselli, Lisa
    De Oliveira, Caroline
    Fridman, Wolf Herve
    Escudier, Bernard
    Sautes-Fridman, Catherine
    Albiges, Laurence
    Chaput-Gras, Nathalie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (05)
12345